Annex

The following entry shall be added at the end of the table in Annex I to Directive 91/414/EC:

Further details on identity and specification of active substance are provided in the review report.
No	Common Name, Identification Numbers	IUPAC Name	Purityf1	Entry into force	Expiration of inclusion	Specific provisions
‘320	Fenbuconazole CAS No: 114369-43-6 CIPAC No: 694	(R,S) 4-(4-chlorophenyl)-2-phenyl-2-(1H-1,2,4-triazol-1-ylmethyl)butyronitrile	≥ 965 g/kg	1 May 2011	30 April 2021	PART A Only uses as fungicide may be authorised. PART B For the implementation of the uniform principles of Annex VI, the conclusions of the review report on fenbuconazole, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 28 October 2010 shall be taken into account. In this overall assessment Member States shall pay particular attention to: the operator safety and ensure that conditions of use prescribe the application of adequate personal protective equipment where appropriate, the dietary exposure of consumers to the residues of triazole derivative metabolites (TDMs), the risk to aquatic organisms and mammals. Conditions of use shall include risk mitigation measures, where appropriate. The Member States concerned shall request the submission of confirmatory data on residues of triazole derivative metabolites (TDMs) in primary crops, rotational crops and products of animal origin. They shall ensure that the applicant provides such studies to the Commission by 30 April 2013. The Member States concerned shall ensure that the applicant submits to the Commission further information addressing the potential endocrine disrupting properties of fenbuconazole within two years after the adoption of the OECD test guidelines on endocrine disruption or, alternatively, of Community agreed test guidelines.’